BioArctic AB (publ) (STO:BIOA.B)
209.20
-6.20 (-2.88%)
Aug 1, 2025, 5:29 PM CET
BioArctic AB Employees
BioArctic AB had 107 employees as of December 31, 2024. The number of employees increased by 19 or 21.59% compared to the previous year.
Employees
107
Change (1Y)
19
Growth (1Y)
21.59%
Revenue / Employee
$13,080,388
Profits / Employee
$7,775,483
Market Cap
18.52B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 107 | 19 | 21.59% |
Dec 31, 2023 | 88 | 27 | 44.26% |
Dec 31, 2022 | 61 | 12 | 24.49% |
Dec 31, 2021 | 49 | 4 | 8.89% |
Dec 31, 2020 | 45 | 3 | 7.14% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
Swedish Orphan Biovitrum AB | 1,806 |
Sectra AB | 1,296 |
Getinge AB | 11,791 |
Camurus AB | 256 |
Medicover AB | 47,256 |
Asker Healthcare Group AB | 4,030 |
Bonesupport Holding AB | 139 |
AddLife AB | 2,181 |
BioArctic AB News
- 2 days ago - BioArtic: Latest data presented at AAIC 2025 reinforces lecanemab's clinical effect with consistent safety profile - PRNewsWire
- 11 days ago - Lecanemab four-year efficacy and safety data to be presented at AAIC 2025 - PRNewsWire
- 17 days ago - The drug discovery research for lecanemab awarded the 9th Bioindustry Award by the Japan Bioindustry Association - PRNewsWire
- 5 weeks ago - BioArctic: Professor Lars Lannfelt to receive the 2025 Hartwig Piepenbrock-DZNE Prize - PRNewsWire
- 7 weeks ago - BioArctic to initiate next cohorts in exidavnemab Phase 2a study after positive safety review - PRNewsWire
- 2 months ago - BioArctic's Capital Markets Day 2025 - entering a new era of growth - PRNewsWire
- 2 months ago - Eisai projects Leqembi® revenue to total JPY 76.5 billion for fiscal year 2025 (April 2025 - March 2026) - PRNewsWire
- 2 months ago - Invitation to presentation of BioArctic's first quarter report for January - March 2025 on May 21 at 9.30 a.m. CET - PRNewsWire